News

A refreshed version of the EASD e-Learning website launches this week, with a cleaner, more user-friendly design.

In a new series of films on Horizons, leading researchers and clinicians from around the world talk about the journal articles that have left a deep impression on their understanding and practice in the fiel...

It’s an increasingly popular way to lose weight and improve health, but which intermittent fasting method should we be prescribing to patients with overweight and obesity? This question was addressed a...

A new review, reported in a recent issue of Diabetologia, looks at glycaemic thresholds for the appearance of the signs and symptoms of hypoglycaemia in people with and without type 1 diabetes. These appear ...

Falls and fractures are more common among people with diabetes, with osteoporosis likely the underlying cause. Bone health, therefore, was under discussion at the ‘complications compendium’ sessi...

Previous research has shown that both type 1 and type 2 diabetes are associated with increased morbidity and mortality from COVID-19 infection. However, we don’t know if this increased risk arises from...

In his new module for EASD e-Learning, Professor Eelco de Koning considers the various options available for restoring normal glucose regulation by replacing insulin-producing cells – whether through i...

The impact of sedentary behaviour in pregnancy and how to address it was a hot topic at the ADA’s latest conference. Lisa Buckingham reports.

Revealing the transcriptome of each pancreatic islet cell type could take us a long way towards clarifying the underlying mechanisms of type 2 diabetes. Single-cell RNA sequencing offers this level of geneti...

Thanks to the GLP-1 receptor agonists and newer, related drugs, it’s now possible to go beyond the traditional glucocentric model of diabetes treatment and address obesity too. The implications of this...

Obstructive sleep apnoea, with its various health consequences, is more common among people with type 2 diabetes than those without the condition. A new study, reported in a recent issue of Diabetologia, fin...

Bariatric surgery can lead to health benefits in type 2 diabetes that go way beyond weight loss and remission. The latest findings in this area were presented at the recent ADA conference, making a strong ca...

A new study in a recent issue of Diabetologia compares intermittent (flash) glucose monitoring with finger-prick testing in a group of pregnant women with type 1 diabetes. While flash did improve glycaemic c...

Counselling and pharmacotherapy can each of them aid weight loss in people with obesity. So what happens when you combine the two? Lisa Buckingham reports on the case for pairing these interventions, as pres...

Tirzepatide is a new class of drug for management of type 2 diabetes. A meta-analysis of its glucose-lowering and weight-loss effects, presented in a recent issue of Diabetologia, will help guide treatment d...

Diabetes is one established risk factor for dementia among many others, so what kind of interventions can reduce risk? This question was addressed at the ADA’s latest conference. Lisa Buckingham reports.

A new analysis of the Global Burden of Disease study, presented in a recent issue of Diabetologia, reveals the geographical variation of type 2 diabetes and how risk factors for the associated morbidity and ...

The centrality of disrupted beta cell function to type 1 diabetes is widely understood. Less commonly appreciated is the vital part it plays in type 2 – a role that takes centre stage in Professor Hind...

Food insecurity is prevalent across the globe, with far-reaching consequences for people’s health and well-being – consequences that can be significantly exacerbated for young people with diabete...

Statins are often prescribed to people with diabetes to reduce their risk of cardiovascular disease. But some clinical trials have reported cases of new-onset diabetes among statin users. Dr Susan Aldridge r...

Plant-based eating is a hot topic and ‘Just how plant-based should people with diabetes go?’ was a question addressed at the ADA’s latest conference. Lisa Buckingham reports.